Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: Differences between children and adults

European Heart Journal

Volumn 35, Issue 1, 2014, Pages

  Lipshultz, Steven E ^a   Wilkinson, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTHRACYCLINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ARRESTIN; CELL SURFACE PROTEIN; CYCLIC AMP; CYTOSKELETON PROTEIN; G PROTEIN COUPLED RECEPTOR; GALECTIN 3; MATRIX METALLOPROTEINASE; MITOCHONDRIAL DNA; NEUROHORMONE;

ADAPTATION; ADRENERGIC SYSTEM; ADULTHOOD; ALLELE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; CARDIAC IMAGING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHILDHOOD; CHILDHOOD CANCER; CHILDHOOD MORTALITY; CHRONOTROPISM; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DOWN REGULATION; FUNCTIONAL DISEASE; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART RATE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HIGH RISK POPULATION; HUMAN; INOTROPISM; MODIFIER GENE; PATHOGENICITY; PHENOTYPE; PRIMARY PREVENTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW; TACHYPHYLAXIS;

ADAPTATION, PHYSIOLOGICAL; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; MALE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 84891822955     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs402     Document Type: Review

References (15)

1. Miyamoto SD, Stauffer BL, Nakano S, Sobus R, Nunley K, Nelson P, Sucharov CC. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 2014;35:33-41.
2. Lipshultz S, Shanfeld J, Chacko S. Emergence of beta-adrenergic sensitivity in the developing chicken heart. Proc Natl Acad Sci USA 1981;78:288-294.
3. Lipshultz SE, Cohen H, Colan SD, Herman EH. The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity. Leuk Lymphoma 2006;47:1454-1458. (Pubitemid 44364007)
4. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348: 1647-655. (Pubitemid 36459470)
5. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, Messere J, Cox GF, Lurie PR, Hsu D, Canter C, Wilkinson JD, Lipshultz SE. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296: 1867-1876. (Pubitemid 44596196)
6. Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, Kantor PF, Alvarez JA, Colan SD, Jefferies JL, Lamour JM, Margossian R, Messere JE, Rusconi PG, Shaddy RE, Towbin JA, Wilkinson JD, Lipshultz SE. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail 2010;3:689-697.
7. Alvarez JA, Orav EJ, Wilkinson JD, Sleeper LA, Fleming LE, Lee DJ, Rusconi PG, Colan SD, Hsu DT, Canter CE, Webber SA, Cox GF, Jefferies JL, Towbin JA, Lipshultz SE, for the Pediatric Cardiomyopathy Registry Investigators. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the Pediatric Cardiomyopathy Registry. Circulation 2011;124: 814-823.
8. Pahl E, Sleeper LA, Canter CE, Hsu DT, Lu M, Webber SA, Colan SD, Kantor PF, Everitt MD, Towbin JA, Jefferies JL, Kaufman BD, Wilkinson JD, Lipshultz SE. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol 2012;59:607-615.
9. Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, Asselin BL, Athale UH, Clavell LA, Laverdiere C, Michon B, Schorin MA, Sallan SE. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol 2012;30:1042-1049.
10. Rusconi PG, Ludwig DA, Ratnasamy C, Mas R, Harmon WG, Colan SD, Lipshultz SE. Serial measurements of NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. Am Heart J 2010:160:776-783.
11. Herman E, Zhang J, Knapton A, Lipshultz SE, Rifai N, Sistare F. Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats. Cardiovasc Toxicol 2006;6:211-221. (Pubitemid 46398617)
12. Zhang J, Knapton A, Lipshultz SE, Weaver JL, Herman EH. Isoproterenol-induced cardiotoxicity in Sprague-Dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury. Toxicol Pathol 2008;36:277-278.
13. Chiang VW, Burns JP, Rifai N, Lipshultz SE, Adams MJ, Weiner DL. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr 2000;137:73-77. (Pubitemid 30470926)
14. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont MEM, Fricker FJ, Lipshultz SE, Perez-Atayde A. Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 1996;31:306-313. (Pubitemid 26089965)
15. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont MEM, Fricker FJ, Lipshultz SE, Perez-Atayde A. Mitochondrial function in children with idiopathic dilated cardiomyopathy. J Inherit Metab Dis 1996;19:309-312 (Pubitemid 26185522)